These independent CME activities are supported by educational grants from Bristol-Myers Squibb.



    Hematology Mastery in
  Multiple Myeloma
  1. Course List
Chair
Noopur Raje, MD
  • Director, Center for Multiple Myeloma
  • MGH Cancer Center
  • Massachusetts General Hospital
  • Boston, Massachusetts

  • Contributing Editor
    Suzanne Lentzsch, MD, PhD

    Faculty
    Jonathan L. Kaufman, MD

    Sagar Lonial, MD
  • Professor, Vice Chair of Clinical Affairs
  • Department of Hematology and Medical Oncology
  • Winship Cancer Institute
  • Emory University School of Medicine
  • Atlanta, Georgia

  • Ajay K. Nooka, MD, MPH
  • Assistant Profesor
  • Division of Bone Marrow Transplant
  • Department of Hematology and Oncology
  • Winship Cancer Institute
  • Atlanta, Georgia
  • Disclosure Information
    Noopur Raje, MD   has received consulting fees from Amgen Inc., Celgene Corporation, Millennium Pharmaceuticals, Inc., and Onyx Pharmaceuticals, Inc.; and has conducted contracted research for Acetylon Pharmaceuticals, Inc. and Eli Lilly and Company.

    Suzanne Lentzsch, MD, PhD   has received consulting fees from Bristol-Myers Squibb, Caelum Biosciences, Inc., Novartis Pharmaceuticals Corporation, and Takeda; has ownership interest in Caelum Biosciences, Inc.

    Jonathan L. Kaufman, MD   has received consulting fees from Amgen Inc., Bristol-Myers Squibb Company, Pharmacyclics LLC, Seattle Genetics, Inc., and Sutro Biopharm, Inc.; and has conducted contracted research for Novartis Pharmaceuticals Corporation and Onyx-Pharma.

    Sagar Lonial, MD   has received consulting fees from Bristol-Myers Squibb, Celgene Corporation, Janssen Pharmaceuticals, Inc., Millennium Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Onyx Pharmaceuticals, Inc., and Sanofi-Aventis.

    Ajay K. Nooka, MD, MPH   has received consulting fees from Amgen Inc., Novartis Pharmaceuticals Corporation, and Spectrum Pharmaceuticals.